Share on StockTwits
 

Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost bought 15,000 shares of the stock in a transaction dated Tuesday, February 25th. The shares were purchased at an average price of $9.03 per share, with a total value of $135,450.00. Following the completion of the purchase, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,947,125. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

OPK has been the subject of a number of recent research reports. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note on Friday, December 20th. Analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note on Wednesday, December 18th.

Shares of Opko Health (NYSE:OPK) traded up 0.22% on Wednesday, hitting $9.08. The stock had a trading volume of 1,109,337 shares. Opko Health has a 1-year low of $6.14 and a 1-year high of $12.95. The stock has a 50-day moving average of $8.37 and a 200-day moving average of $9.21. The company’s market cap is $3.705 billion.

OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.